Cardiac Adrenoceptors: Physiological and Pathophysiological Relevance

Journal of Pharmacological Sciences - Tập 100 - Trang 323-337 - 2006
Otto-Erich Brodde1, Heike Bruck1, Kirsten Leineweber1
1Departments of Pathophysiology and Nephrology, University of Essen School of Medicine, Hufelandstr. 55, D-45147 Essen, Germany

Tài liệu tham khảo

1 Bylund DB, Bond RA, Clarke DE, Eikenburg DC, Hieble JP, Langer SZ, et al. Adrenoceptors. The IUPHAR compendium of receptor characterization and classification. London: IUPHAR Media; 1998, p. 58–74.

BRODDE O-E, 1999, 51, 651

3 Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G-protein. Circulation. 1999;100:2210–2212.

1995, 47, 322

9 Xiao R-P, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Recent advances in cardiac &beta;<sub>2</sub>-adrenergic signal transduction. Circ Res. 1999;85:1092&ndash;1100.

10.1161/01.CIR.0000087595.17277.73

16 Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, et al. &beta;<sub>2</sub>-Adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G<sub>s</sub> and G<sub>i</sub>. Circ Res. 2000;87:705&ndash;709.

10.1007/BF00408647

18 Kaumann A, Bartel S, Molenaar P, Sanders L, Burrell K, Vetter D, et al. Activation of &beta;<sub>2</sub>-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation. 1999;99:65&ndash;72.

19 Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P, et al. Both &beta;<sub>2</sub>- and &beta;<sub>1</sub>-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of &beta;<sub>2</sub>-adrenergic receptors to G<sub>s</sub>-protein. Circulation. 2000;102:1814&ndash;1821.

10.1161/01.CIR.0000017187.61348.95

10.1161/01.RES.0000102042.83024.CA

10.1016/S0165-6147(00)01562-5

1988, 247, 1039

1993, 45, 147

10.1016/S0024-3205(96)00650-9

10.1161/01.CIR.0000139844.15045.F9

10.1016/S1050-1738(00)00053-0

10.1016/S0898-6568(03)00099-8

10.1016/S0735-1097(03)01063-5

66 Li Z, Laugwitz K-L, Pinkernell K, Pragst I, Baumgartner C, Hoffmann E, et al. Effects of two G&beta;&gamma;-binding proteins &ndash; N-terminally truncated phosducin and &beta;-adrenergic receptor kinase C terminus (&beta;ARKct) &ndash; in heart failure. Gene Therapy. 2003;10:1354&ndash;1361.

69 Leineweber K, B&uuml;scher R, Bruck H, Brodde O-E. &beta;-Adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:1&ndash;22.

10.1074/jbc.M200681200

10.1016/S0735-1097(02)02137-X

10.1097/00008571-200104000-00003

10.1016/S0009-9236(02)17734-4

10.1016/S0009-9236(03)00224-8

10.1016/S0009-9236(03)00068-7

10.1016/S1388-9842(03)00044-8

10.1056/NEJMoa020803

103 Brodde O-E, Leineweber K. &beta;<sub>2</sub>-Adrenoceptor gene polymorphisms. Pharmacogenet Genomics. 2005;15:267&ndash;275.

1993, 268, 23116, 10.1016/S0021-9258(19)49434-9

107 Brodde O-E, B&uuml;scher R, Tellkamp R, Radke J, Dhein S, Insel PA. Blunted cardiac responses to receptor activation in subjects with Thr164Ile &beta;<sub>2</sub>-adrenoceptors. Circulation. 2001;103:1048&ndash;1050.

GRATZE G, 1999, 33, 1425, 10.1161/01.HYP.33.6.1425

10.1016/S0002-8703(00)90099-1

10.1042/CS20020299

114 Cockroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, et al. &beta;<sub>2</sub>-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 2000;36:371&ndash;375.

10.1056/NEJMoa010819

10.1097/00008571-200302000-00001

121 Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, et al. Polymorphisms of the &beta;<sub>2</sub>-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res. 2000;86:834&ndash;840.

10.1016/S0140-6736(04)17273-5

10.1016/S0009-9236(03)00223-6